MassBio Forum: Doing Business in China, Trade Friction or Pharma Fusion?

By: John Hession This week I attended a MassBio Forum Panel on Doing Business With China: Changing Regulatory Reforms and BD Opportunities in China. The panel members were Kate Haviland, Chief Business Officer at Blueprint Bio; Wei Zhao, Vice President at VP 6 Dimensions (Wuxi Ventures); and Kenneth Zhou, Partner at WilmerHale. The moderator was Ryan Roller, …

Continue reading MassBio Forum: Doing Business in China, Trade Friction or Pharma Fusion?

Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series, June 28

Due to overwhelming demand for our April 28 "Strategic Alliances: Pot of Gold or Pretty Poison?" event, we will be holding another round on Wednesday, June 28 at the Cambridge Innovation Center (CIC). Moderated by corporate attorney John Hession, a panel of business development experts will explore various research and collaboration structures, from options to license to comprehensive …

Continue reading Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series, June 28

Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28

Our Life Sciences Series Panel 4 event, Strategic Alliances: Pot of Gold or Pretty Poison?, will be held on Friday, April 28 from 7:30-10am in our Waltham office. Moderated by corporate attorney John Hession, a panel of business development experts from Big Pharma and Small Biotech explore various research and collaboration structures, from options to license …

Continue reading Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28